Volume 10 Issue 1
Jan.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(1): 1-9
Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for diagnosis and treatment of post transplantation diabetes mellitus in China (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 1-9. doi: 10.3969/j.issn.1674-7445.2019.01.001
Citation: Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for diagnosis and treatment of post transplantation diabetes mellitus in China (2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 1-9. doi: 10.3969/j.issn.1674-7445.2019.01.001
shu

Technical specifcation for diagnosis and treatment of post transplantation diabetes mellitus in China (2019 edition)

doi: 10.3969/j.issn.1674-7445.2019.01.001
  • Received Date: 2018-11-01
    Available Online: 2021-01-19
  • Publish Date: 2019-01-15
    Abstract
    • FullText(HTML)
  • loading
    • References(58)
  • [1]
    VALDERHAUG TG, HJELMESÆTH J, JENSSEN T, et al.Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses[J].Transplantation, 2012, 94(7):714-720.DOI: 10.1097/TP.0b013e31825f4434.
    [2]
    SIRAJ ES, ABACAN C, CHINNAPPA P, et al.Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients[J].Transplant Proc, 2010, 42(5):1685-1689.DOI:10.1016/ j.transproceed.2009.12.062.
    [3]
    COLE EH, JOHNSTON O, ROSE CL, et al.Impact of acute rejection and new-onset diabetes on longterm transplant graft and patient survival[J].Clin J Am Soc Nephrol, 2008, 3(3):814-821.DOI:10.2215/ CJN.04681107.
    [4]
    WAUTERS RP, COSIO FG, SUAREZ FERNANDEZ ML, et al.Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation[J].Transplantation, 2012, 94(4):377-382. doi: 10.1097/TP.0b013e3182584831
    [5]
    DAVIDSON J, WILKINSON A, DANTAL J, et al.Newonset diabetes after transplantation:2003 international consensus guidelines.proceedings of an international expert panel meeting.Barcelona, Spain, 19 February 2003[J].Transplantation, 2003, 75(10 Suppl):SS3-SS24. http://www.ncbi.nlm.nih.gov/pubmed/12775942
    [6]
    SHARIF A, HECKING M, DE VRIES AP, et al.Proceedings from an international consensus meeting on posttransplantation diabetes mellitus:recommendations and future directions[J].Am J Transplant, 2014, 14(9):1992-2000.DOI: 10.1111/ajt.12850.
    [7]
    CHAKKERA HA, WEIL EJ, CASTRO J, et al.Hyperglycemia during the immediate period after kidney transplantation[J].Clin J Am Soc Nephrol, 2009, 4(4):853-859.DOI: 10.2215/CJN.05471008.
    [8]
    COTOVIO P, NEVES M, RODRIGUES L, et al.Newonset diabetes after transplantation:assessment of risk factors and clinical outcomes[J].Transplant Proc, 2013, 45(3):1079-1083.DOI: 10.1016/j.transproceed.2013.03.009.
    [9]
    BAYER ND, COCHETTI PT, ANIL KUMAR MS, et al.Association of metabolic syndrome with development of new-onset diabetes after transplantation[J].Transplantation, 2010, 90(8):861-866.DOI: 10.1097/TP.0b013e3181f1543c.
    [10]
    U.S.Renal Data System.USRDS 2013 Annual Data Report:atlas of chronic kidney disease and end-stage renal disease in the United States[M].Bethesda:National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013.
    [11]
    CHAKKERA HA, WEIL EJ, PHAM PT, et al.Can newonset diabetes after kidney transplant be prevented?[J].Diabetes Care, 2013, 36(5):1406-1412.DOI:10.2337/ dc12-2067.
    [12]
    CAILLARD S, EPRINCHARD L, PERRIN P, et al.Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients:role of systematic screening by oral glucose tolerance test[J].Transplantation, 2011, 91(7):757-764.DOI: 10.1097/TP.0b013e31820f0877.
    [13]
    HORNUM M, JØRGENSEN KA, HANSEN JM, et al.New-onset diabetes mellitus after kidney transplantation in Denmark[J].Clin J Am Soc Nephrol, 2010, 5(4):709- 716.DOI: 10.2215/CJN.05360709.
    [14]
    HECKING M, WERZOWA J, HAIDINGER M, et al.Novel views on new-onset diabetes after transplantation:development, prevention and treatment[J].Nephrol Dial Transplant, 2013, 28(3):550-566.DOI:10.1093/ndt/ gfs583.
    [15]
    LUND LH, EDWARDS LB, KUCHERYAVAYA AY, et al.The Registry of the International Society for Heart and Lung Transplantation:Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme:early graft failure[J].J Heart Lung Transplant, 2015, 34(10):1244- 1254.DOI: 10.1016/j.healun.2015.08.003.
    [16]
    ABE T, ONOE T, TAHARA H, et al.Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation[J].Transplant Proc, 2014, 46(3):865-869.DOI: 10.1016/j.transproceed.2013.12.027.
    [17]
    HACKMAN KL, SNELL GI, BACH LA.Prevalence and predictors of diabetes after lung transplantation:a prospective, longitudinal study[J].Diabetes Care, 2014, 37(11):2919-2925.DOI: 10.2337/dc14-0663.
    [18]
    BERGREM HA, VALDERHAUG TG, HARTMANN A, et al.Undiagnosed diabetes in kidney transplant candidates:a case-finding strategy[J].Clin J Am Soc Nephrol, 2010, 5(4):616-622.DOI: 10.2215/CJN.07501009.
    [19]
    TUFTON N, AHMAD S, ROLFE C, et al.New-onset diabetes after renal transplantation[J].Diabet Med, 2014, 31(11):1284-1292.DOI: 10.1111/dme.12534.
    [20]
    HAGEN M, HJELMESAETH J, JENSSEN T, et al.A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients[J].Nephrol Dial Transplant, 2003, 18(10):2154-2159. doi: 10.1093/ndt/gfg338
    [21]
    NAM JH, MUN JI, KIM SI, et al.beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus[J].Transplantation, 2001, 71(10):1417- 1423. doi: 10.1097/00007890-200105270-00011
    [22]
    SHIMIZU M, IINO Y, TERASHI A.Improvement of insulin sensitivity after renal transplantation measured by a glucose clamp technique[J].Nihon Ika Daigaku Zasshi, 1998, 65(1):50-54. doi: 10.1272/jnms1923.65.50
    [23]
    HECKING M, HAIDINGER M, DÖLLER D, et al.Early basal insulin therapy decreases new-onset diabetes after renal transplantation[J].J Am Soc Nephrol, 2012, 23(4):739-749.DOI: 10.1681/ASN.2011080835.
    [24]
    HEIT JJ, APELQVIST AA, GU X, et al.Calcineurin/ NFAT signalling regulates pancreatic beta-cell growth and function[J].Nature, 2006, 443(7109):345-349. doi: 10.1038/nature05097
    [25]
    REDMON JB, OLSON LK, ARMSTRONG MB, et al.Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells[J].J Clin Invest, 1996, 98(12):2786-2793. doi: 10.1172/JCI119105
    [26]
    HEROLD KC, NAGAMATSU S, BUSE JB, et al.Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506[J].Transplantation, 1993, 55(1):186-192. doi: 10.1097/00007890-199301000-00035
    [27]
    VINCENTI F, FRIMAN S, SCHEUERMANN E, et al.Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J].Am J Transplant, 2007, 7(6):1506-1514. doi: 10.1111/ajt.2007.7.issue-6
    [28]
    HUSCHER D, THIELE K, GROMNICA-IHLE E, et al.Dose-related patterns of glucocorticoid-induced side effects[J].Ann Rheum Dis, 2009, 68(7):1119-1124.DOI: 10.1136/ard.2008.092163.
    [29]
    QI D, RODRIGUES B.Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism[J].Am J Physiol Endocrinol Metab, 2007, 292(3):E654-E667. doi: 10.1152/ajpendo.00453.2006
    [30]
    ULLRICH S, BERCHTOLD S, RANTA F, et al.Serumand glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion[J].Diabetes, 2005, 54(4):1090-1099. doi: 10.2337/diabetes.54.4.1090
    [31]
    BECKER B, KRONENBERG F, KIELSTEIN JT, et al.Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease:the mild and moderate kidney disease study[J].J Am Soc Nephrol, 2005, 16(4):1091-1098. doi: 10.1681/ASN.2004090742
    [32]
    KASISKE BL, SNYDER JJ, GILBERTSON D, et al.Diabetes mellitus after kidney transplantation in the United States[J].Am J Transplant, 2003, 3(2):178-185. doi: 10.1034/j.1600-6143.2003.00010.x
    [33]
    ORTEGA-CAMARILLO C, GUZMÁN-GRENFELL AM, GARCÍA-MACEDO R, et al.Hyperglycemia induces apoptosis and p53 mobilization to mitochondria in RINm5F cells[J].Mol Cell Biochem, 2006, 281(1/2):163-171. http://www.ncbi.nlm.nih.gov/pubmed/16328969?dopt=Abstract&holding=npg
    [34]
    SMILEY DD, UMPIERREZ GE.Perioperative glucose control in the diabetic or nondiabetic patient[J].South Med J, 2006, 99(6):580-591. doi: 10.1097/01.smj.0000209366.91803.99
    [35]
    RABKIN R, RYAN MP, DUCKWORTH WC.The renal metabolism of insulin[J].Diabetologia, 1984, 27(3):351- 357. doi: 10.1007/BF00304849
    [36]
    CLEMENT S, BRAITHWAITE SS, MAGEE MF, et al.Management of diabetes and hyperglycemia in hospitals[J].Diabetes Care, 2004, 27(2):553-591. doi: 10.2337/diacare.27.2.553
    [37]
    OPELZ G, DÖHLER B.Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers[J].Transplantation, 2014, 97(3):310-315.DOI: 10.1097/01.TP.0000437672.78716.28.
    [38]
    HACKMAN KL, BAILEY MJ, SNELL GI, et al.Diabetes is a major risk factor for mortality after lung transplantation[J].Am J Transplant, 2014, 14(2):438- 445.DOI: 10.1111/ajt.12561.
    [39]
    LANGSFORD D, DWYER K.Dysglycemia after renal transplantation:definition, pathogenesis, outcomes and implications for management[J].World J Diabetes, 2015, 6(10):1132-1151.DOI: 10.4239/wjd.v6.i10.1132.
    [40]
    YATES CJ, FOURLANOS S, COLMAN PG, et al.Screening for new-onset diabetes after kidney transplantation:limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin[J].Transplantation, 2013, 96(8):726-731.DOI: 10.1097/TP.0b013e3182a012f3.
    [41]
    WILKINSON A, DAVIDSON J, DOTTA F, et al.Guidelines for the treatment and management of newonset diabetes after transplantation[J].Clin Transplant, 2005, 19(3):291-298. doi: 10.1111/ctr.2005.19.issue-3
    [42]
    PHAM PT, PHAM PM, PHAM SV, et al.New onset diabetes after transplantation (NODAT):an overview[J].Diabetes Metab Syndr Obes, 2011, 4:175-186.DOI: 10.2147/DMSO.S19027.
    [43]
    JUAN KHONG M, PING CHONG CH.Prevention and management of new-onset diabetes mellitus in kidney transplantation[J].Neth J Med, 2014, 72(3):127-134. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=a2d09f9a472edf74c11f01afc1246a92
    [44]
    COSIO FG, KUDVA Y, VAN DER VELDE M, et al.New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation[J].Kidney Int, 2005, 67(6):2415-2421. doi: 10.1111/j.1523-1755.2005.00349.x
    [45]
    SHIVASWAMY V, BOERNER B, LARSEN J.Posttransplant diabetes mellitus:causes, treatment, and impact on outcomes[J].Endocr Rev, 2016, 37(1):37-61.DOI: 10.1210/er.2015-1084.
    [46]
    Kidney Disease:Improving Global Outcomes (KDIGO) Transplant Work Group.KDIGO clinical practice guideline for the care of kidney transplant recipients[J].Am J Transplant, 2009, 9 (Suppl 3):S1-S155.DOI:10.1111/ j.1600-6143.2009.02834.x.
    [47]
    DAVIDSON JA, WILKINSON A, International Expert Panel on New-Onset Diabetes after Transplantation.NewOnset Diabetes After Transplantation 2003 International Consensus Guidelines:an endocrinologist's view[J].Diabetes Care, 2004, 27(3):805-812. doi: 10.2337/diacare.27.3.805
    [48]
    YOUNG-HYMAN DL, DAVIS CL.Disordered eating behavior in individuals with diabetes:importance of context, evaluation, and classification[J].Diabetes Care, 2010, 33(3):683-689.DOI: 10.2337/dc08-1077.
    [49]
    American Diabetes Association.Classification and diagnosis of diabetes:standards of medical care in diabetes-2018[J].Diabetes Care, 2018, 41(Suppl 1):S13-S27.DOI: 10.2337/dc18-S002.
    [50]
    LI Y, XU W, LIAO Z, et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J].Diabetes Care, 2004, 27(11):2597-2602. doi: 10.2337/diacare.27.11.2597
    [51]
    WENG J, LI Y, XU W, et al.Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:a multicentre randomised parallel-group trial[J].Lancet, 2008, 371(9626):1753-1760. doi: 10.1016/S0140-6736(08)60762-X
    [52]
    JENSSEN T, HARTMANN A.Prevention and management of transplant-associated diabetes[J].Expert Opin Pharmacother, 2011, 12(17):2641-2655.DOI: 10.1517/14656566.2011.628936.
    [53]
    MORA S, AMES JM, MANSON JE.Low-dose aspirin in the primary prevention of cardiovascular disease:shared decision making in clinical practice[J].JAMA, 2016, 316(7):709-710.DOI: 10.1001/jama.2016.8362.
    [54]
    BAX JJ, YOUNG LH, FRYE RL, et al.Screening for coronary artery disease in patients with diabetes[J].Diabetes Care, 2007, 30(10):2729-2736. doi: 10.2337/dc07-9927
    [55]
    BODEN WE, O'ROURKE RA, TEO KK, et al.Optimal medical therapy with or without PCI for stable coronary disease[J].N Engl J Med, 2007, 356(15):1503-1516. doi: 10.1056/NEJMoa070829
    [56]
    BHATT DL, BONACA MP, BANSILAL S, et al.Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUSTIMI 54[J].J Am Coll Cardiol, 2016, 67(23):2732-2740.DOI: 10.1016/j.jacc.2016.03.529.
    [57]
    BARI 2D Study Group, FRYE RL, AUGUST P, et al.A randomized trial of therapies for type 2 diabetes and coronary artery disease[J].N Engl J Med, 2009, 360(24):2503-2515.DOI: 10.1056/NEJMoa0805796.
    [58]
    WACKERS FJ, CHYUN DA, YOUNG LH, et al.Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study[J].Diabetes Care, 2007, 30(11):2892-2898. doi: 10.2337/dc07-1250
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (305) PDF downloads(105) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return